Catalyst Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Go back to Catalyst Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Catyalyst Pharma (CPRX) Reports In-Line Q3 EPS

November 7, 2018 4:43 PM EST

Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

... More